Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Application of Biomarkers of Renal Damage in Patients Treated With Immune Checkpoint Inhibitors

NCT04902846 is registered in ClinicalTrials.gov with R. Laura Vicente Vicente as lead sponsor.

NCT NCT04902846
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04902846 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Application of Biomarkers of Renal Damage in Patients Treated With Immune Checkpoint Inhibitors
Lead sponsor
R. Laura Vicente Vicente
Phase
Observational
Overall status
Recruiting
Start date
May 19, 2021
Completion date
December 30, 2030
Enrollment
220 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

antineoplastics toxicity, kidney injury